Lei Liu, Changfa Wang, Zhongyang Hu, Kui Chen, Yaqin Wang
{"title":"Cumulative Exposure to High Systemic Inflammation and Incident Metabolic Dysfunction-Associated Steatotic Liver Disease: A Longitudinal Cohort Study.","authors":"Lei Liu, Changfa Wang, Zhongyang Hu, Kui Chen, Yaqin Wang","doi":"10.7570/jomes25087","DOIUrl":"https://doi.org/10.7570/jomes25087","url":null,"abstract":"<p><strong>Background: </strong>This study aimed to examine the association between cumulative exposure to systemic inflammation and incident metabolic dysfunction-associated steatotic liver disease (MASLD) and related liver fibrosis in mainland China.</p><p><strong>Methods: </strong>This study used data from an ongoing longitudinal physical examination cohort. We enrolled 9,725 participants (aged ≥18 years) who completed three consecutive biennial health examinations between 2018 and 2022, with complete follow-up in 2024. Systemic inflammation was quantified using three established biomarkers: neutrophil count (NC), neutrophil-to-lymphocyte ratio (NLR), and systemic immune-inflammation index (SII). Cumulative exposure was calculated from baseline to the third examination by multiplying biomarker values by the time (years) between consecutive examinations. The primary outcome was MASLD development at the fourth examination, and advanced liver fibrosis among incident MASLD cases was further evaluated using the fibrosis-4 index (≥2.67). Multivariable logistic regression models were used to explore the associations between cumulative exposure to inflammation and MASLD incidence and fibrosis severity.</p><p><strong>Results: </strong>At the fourth examination, 939 incident MASLD cases (9.66%) were identified. In fully adjusted models, participants in the highest quartile of cumulative NC exposure had 2.20-fold higher odds of MASLD (95% confidence interval [CI], 1.81 to 2.69; <i>P</i> for trend <0.001) than those in the lowest quartile. Similarly, the highest quartile of cumulative SII exposure had 1.32-fold higher odds (95% CI, 1.09 to 1.59; <i>P</i> for trend=0.003). Conversely, cumulative NLR exposure showed no significant association with MASLD incidence. The addition of cumulative NC or SII to the basic model comprising traditional risk factors improved the ability to predict MASLD. Furthermore, among participants who developed MASLD, the highest quartile of cumulative NC (odds ratio [OR], 4.74; 95% CI, 1.76 to 12.75; <i>P</i> for trend <0.001) and cumulative SII (OR, 3.74; 95% CI, 1.48 to 9.45; <i>P</i> for trend=0.006), but not cumulative NLR, were significantly associated with an elevated risk of advanced liver fibrosis.</p><p><strong>Conclusion: </strong>Greater NC exposure and excessive SII exposure were each independently associated with incident MASLD and related advanced liver fibrosis. Whether reducing inflammation can help prevent MASLD requires further investigation.</p>","PeriodicalId":45386,"journal":{"name":"Journal of Obesity & Metabolic Syndrome","volume":" ","pages":""},"PeriodicalIF":12.7,"publicationDate":"2026-10-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149225210","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Effects of Different Exercise Modalities on Interleukin-6, Brain-Derived Neurotrophic Factor, and Cognitive Function in Obese Older Women.","authors":"Kun-Ho Lee, Chan Yang Kim, Yun-A Shin","doi":"10.7570/jomes25075","DOIUrl":"https://doi.org/10.7570/jomes25075","url":null,"abstract":"<p><strong>Background: </strong>This study examined the effects of different exercise modalities on body composition, interleukin-6 (IL-6), and cognitive function in obese older women.</p><p><strong>Methods: </strong>A total of 54 women aged ≥65 years were randomized to the control (CON), aerobic aquatic exercise (AAE), aerobic dance exercise (ADE), or combined aerobic and resistance exercise (AE+RE) groups.</p><p><strong>Results: </strong>Significant time-by-group interactions were observed for body weight (BW), body fat percentage (%BF), IL-6, and Korean version of the Mini-Mental State Examination (MMSE-K) scores. The AAE and ADE groups showed significant reductions in BW and %BF, and fat-free mass increased only in the AAE group (<i>P</i><0.01). brain-derived neurotrophic factor (BDNF) increased in the AAE and ADE groups (both <i>P</i><0.01), whereas IL-6 decreased in both groups (ADE, <i>P</i><0.05; AAE, <i>P</i><0.01). MMSE-K scores improved in all exercise groups, with scores in the AE+RE and AAE groups significantly higher than those in the CON group (<i>P</i><0.001 and <i>P</i><0.01, respectively).</p><p><strong>Conclusion: </strong>Moderate-intensity aquatic and dance-based aerobic exercise over 12 weeks improved both metabolic health and cognitive function in obese older women and was accompanied by reductions in IL-6 and increases in BDNF.</p>","PeriodicalId":45386,"journal":{"name":"Journal of Obesity & Metabolic Syndrome","volume":" ","pages":""},"PeriodicalIF":12.7,"publicationDate":"2026-10-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149225164","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Yueqing Liang, Xin Luo, Xueyi Jiang, Tianyi Teng, Kemin Qi, Ping Li
{"title":"Relationship between Vitamin D Status and the Risk of Obesity without Diagnosed Metabolic Syndrome: A Meta-Analysis of Observational Studies.","authors":"Yueqing Liang, Xin Luo, Xueyi Jiang, Tianyi Teng, Kemin Qi, Ping Li","doi":"10.7570/jomes25048","DOIUrl":"https://doi.org/10.7570/jomes25048","url":null,"abstract":"<p><strong>Background: </strong>The association between daily vitamin D (VD) intake and the risk of healthy obesity remains controversial.</p><p><strong>Methods: </strong>PubMed, Embase, Web of Science, Wanfang Database, China Science and Technology Periodical Database, and the Cochrane Database of Systematic Reviews were systematically searched for published observational studies up to January 2025. Ultimately, 74 studies were included, and pooled estimates were obtained using RevMan version 5.3. Subgroup analyses were conducted by age, VD detection method and assessment criteria, and obesity grade.</p><p><strong>Results: </strong>Among 5,283 articles identified, 74 studies with 110,838 individuals met the inclusion criteria. Serum/plasma 25-hydroxyvitamin D concentrations were negatively associated with the risk of healthy obesity (mean difference=-3.98; 95% confidence interval [CI], -4.70 to -3.27). Significant differences between the obesity and control groups were observed in all subgroups except those using liquid chromatography-tandem mass spectrometry/mass spectrometry (LC-MS/MS) detection. Moreover, the prevalence of VD deficiency was higher in participants with obesity than in controls (odds ratio [OR], 2.02; 95% CI, 1.73 to 2.36). This difference was significant in all subgroups except those in which VD deficiency was defined as a concentration below 10 or 12 ng/mL. Furthermore, VD insufficiency was positively associated with the risk of obesity (OR, 1.17; 95% CI, 1.04 to 1.32). However, significant differences were observed only in specific subgroups: adolescents, participants with mild obesity, and those assessed using enzyme-linked immunosorbent assay or LC-MS/MS detection methods.</p><p><strong>Conclusion: </strong>These findings indicated that VD status was inversely associated with the risk of healthy obesity, irrespective of age and obesity grade. Inconsistencies may be influenced by VD detection methods and assessment criteria.</p>","PeriodicalId":45386,"journal":{"name":"Journal of Obesity & Metabolic Syndrome","volume":" ","pages":""},"PeriodicalIF":12.7,"publicationDate":"2026-10-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149220871","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Ji Won Park, Minku Kang, Eungu Kang, Hyo-Kyoung Nam, Kee-Hyoung Lee, Young-Jun Rhie
{"title":"Impact of COVID-19 on Childhood Obesity in South Korea: Variations by Age and Sex.","authors":"Ji Won Park, Minku Kang, Eungu Kang, Hyo-Kyoung Nam, Kee-Hyoung Lee, Young-Jun Rhie","doi":"10.7570/jomes25054","DOIUrl":"https://doi.org/10.7570/jomes25054","url":null,"abstract":"<p><strong>Background: </strong>The prevalence of overweight and obesity among children and adolescents has risen over recent decades, although the increase has recently stabilized. The coronavirus disease 2019 (COVID-19) pandemic was accompanied by substantial weight gain among Korean children. We examined changes in the prevalence of overweight and obesity among South Korean children from 2017 to 2021, including the pandemic period.</p><p><strong>Methods: </strong>We analyzed data from the Korea National Health and Nutrition Examination Survey from 2017 to 2021 to compare the prevalence of overweight and obesity before and during the COVID-19 pandemic. The study included 6,249 participants, with subgroup analyses by sex and age (2-9 and 10-18 years). Changes in lifestyle among adolescents aged 12-18 years were assessed using survey responses.</p><p><strong>Results: </strong>Mean body mass index increased significantly during the COVID-19 period among boys in both age groups (<i>P</i><0.05). The prevalence of obesity among Korean children also increased markedly (<i>P</i><0.05). Among children aged 10-18 years, boys had a notable increase in obesity prevalence during the pandemic, whereas girls did not have a statistically significant increase.</p><p><strong>Conclusion: </strong>The COVID-19 pandemic period was associated with a marked increase in the overall prevalence of obesity and extreme obesity among Korean children, particularly boys aged 10-18 years. Differences in lifestyle factors by sex and age may have contributed to the observed variation in obesity prevalence.</p>","PeriodicalId":45386,"journal":{"name":"Journal of Obesity & Metabolic Syndrome","volume":" ","pages":""},"PeriodicalIF":12.7,"publicationDate":"2026-10-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149220808","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Perspectives on Community-Based Pediatric Obesity Prevention and Management Programs in South Korea: A Qualitative Interview Study of School and Local Public Health Center Providers.","authors":"Sujin Park, Hyo Seon Jeong, Young-Min Noh, Eungu Kang, Yong Hee Hong, Sochung Chung","doi":"10.7570/jomes25099","DOIUrl":"https://doi.org/10.7570/jomes25099","url":null,"abstract":"<p><strong>Background: </strong>Pediatric obesity has increased globally, and South Korea has reported the highest prevalence in East Asia. Despite national policies addressing children's nutrition and health, fragmented governance and overlapping programs may limit their effectiveness. We compared education and public health providers' perspectives to identify barriers to pediatric obesity prevention and management (POPM) in South Korea and inform an integrated operational model.</p><p><strong>Methods: </strong>This qualitative study included in-depth and focus group interviews with 25 POPM providers from 18 education and public health institutions. The interview guide addressed program operations, strategies, collaboration, treatment referrals, vulnerable populations, implementation facilitators, and optimal program design.</p><p><strong>Results: </strong>Both sectors prioritized physical activity and nutrition and used physical assessments. Schools targeted individual students, whereas public health centers targeted institutions. Barriers included low participation, limited resources, weak coordination, and inconsistent referral pathways, with few services for out-of-school youth. Suggested facilitators included greater parental awareness, provider training, clear guidance, stronger community linkages, and adequate funding.</p><p><strong>Conclusion: </strong>Providers' accounts of fragmented roles, weak coordination, and referral gaps support consideration of a school-centered model with local public health center support and clearly defined institutional roles. Such a model would require sustained support for participation, implementation guidance, and workforce development. It would also require clinical referral pathways, including for medically vulnerable children, and improved data infrastructure.</p>","PeriodicalId":45386,"journal":{"name":"Journal of Obesity & Metabolic Syndrome","volume":" ","pages":""},"PeriodicalIF":12.7,"publicationDate":"2026-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149184703","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Health Policy for Obesity and Metabolic Syndrome in Asian Health Systems: Three Design Principles, Three Binding Constraints, and the Governance That Decides between Them.","authors":"Sunyoung Kim, Sang Youl Rhee","doi":"10.7570/jomes26017","DOIUrl":"https://doi.org/10.7570/jomes26017","url":null,"abstract":"<p><strong>Background: </strong>Obesity drives metabolic syndrome and cardiometabolic disease in Asia, where complications develop at lower levels of adiposity than in Western populations. We reviewed Asian obesity policies to identify design features that support their durability and how access to incretin-based medications fits within these policies.</p><p><strong>Methods: </strong>This narrative review used a structured search of PubMed/MEDLINE and Embase (January 2000 to March 2025) supplemented by grey literature from public health agencies. Of 1,884 records, 612 underwent full-text review and 236 met inclusion criteria. Two reviewers screened independently, resolving disagreements by consensus. Evidence was grouped into healthcare-based prevention and treatment, fiscal and regulatory measures, food and physical activity environments, digital health, and pharmacotherapy access.</p><p><strong>Results: </strong>We examined Japan's Specific Health Checkup, Korea's National Health Screening Program, Singapore's Nutri-Grade scheme, and sugar-sweetened beverage taxes in Thailand, Malaysia, and the Philippines. Three design principles emerged: holding insurers accountable for population metabolic screening, scheduling excise tax increases in advance, and adapting regulation to local food settings, including freshly prepared foods. Their effectiveness was limited by stigma in workplace screening, limited reach into the informal food sector, and lower uptake in rural and digitally underserved populations. Policy durability depended more on governance than on individual measures.</p><p><strong>Conclusion: </strong>Obesity policy in Asia requires governance mechanisms built into its design: a permanent inter-agency body with protected funding, legal safeguards against industry interference, and mandatory equity audits with independent monitoring. Access to incretin-based medications belongs in the same framework; otherwise, these drugs may widen regional inequities.</p>","PeriodicalId":45386,"journal":{"name":"Journal of Obesity & Metabolic Syndrome","volume":" ","pages":""},"PeriodicalIF":12.7,"publicationDate":"2026-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149184662","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Advantages and Critical Reappraisal of New Clinical Obesity Definition Proposed by Lancet Commission.","authors":"Soo Lim, Hun Jee Choe, Donna H Ryan","doi":"10.7570/jomes26008","DOIUrl":"https://doi.org/10.7570/jomes26008","url":null,"abstract":"<p><p>Obesity has traditionally been defined by body mass index (BMI), a pragmatic but biologically limited measure that fails to capture adiposity distribution, tissue dysfunction, and heterogeneity in disease risk. To address these limitations, a recent <i>Lancet Diabetes & Endocrinology</i> Commission proposed a disease-oriented redefinition of obesity, distinguishing clinical obesity-excess adiposity causing organ dysfunction or functional impairment-from preclinical obesity, characterized by excess adiposity without established dysfunction. This shift has important implications for diagnosis, epidemiology, and health policy. In this review, we critically appraise the conceptual framework, emerging evidence, and implementation challenges of the new Lancet Commission definition of clinical obesity. Population-based studies from diverse regions consistently demonstrate marked discordance between BMI-defined and clinical obesity, with clinical obesity showing stronger associations with cardiometabolic disease, mortality, functional limitation, and cancer risk. These findings highlight the limitations of universal BMI thresholds, particularly in Asian populations with a predisposition to visceral adiposity at lower BMI levels. We compare the Lancet Commission framework with existing staging systems, including the Edmonton Obesity Staging System and the European Association for the Study of Obesity framework, and identify key challenges related to causal attribution, binary classification, scalability, and ethnic adaptation. Finally, we propose a refined, population-sensitive and pragmatic approach that conceptualizes preclinical and clinical obesity as stages along a trajectory, incorporates ethnicity-adapted adiposity thresholds, and emphasizes readily available clinical criteria for determining dysfunction and disease. The resulting definition of clinical obesity should support more precise and equitable obesity care.</p>","PeriodicalId":45386,"journal":{"name":"Journal of Obesity & Metabolic Syndrome","volume":" ","pages":""},"PeriodicalIF":12.7,"publicationDate":"2026-10-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149128712","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"The Future of Metabolic and Bariatric Surgery in the Glucagon-Like Peptide-1 Era: Has the Scalpel Become Obsolete?","authors":"Paul Wong, Abdelrahman Nimeri","doi":"10.7570/jomes26007","DOIUrl":"https://doi.org/10.7570/jomes26007","url":null,"abstract":"<p><p>Obesity remains a growing global health crisis, affecting nearly one billion adults worldwide and substantially increasing the risk of cardiometabolic disease, malignancy, and premature mortality. Metabolic and bariatric surgery (MBS) has evolved into an effective and durable treatment for severe obesity, providing sustained weight loss and significant remission of obesity-related comorbidities (i.e., type 2 diabetes mellitus and cardiovascular disease). Despite dramatic improvements in safety, efficacy, and long-term outcomes over time, MBS remains markedly underutilized, reaching fewer than 1% of eligible patients. Persistent barriers include limited patient and provider awareness, misconceptions regarding surgical risk, and significant disparities in access to care. Concurrently, the rapid adoption of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) has transformed the medical management of obesity, offering effective pharmacologic weight loss but raising questions regarding their impact on MBS utilization, durability, and cost-effectiveness. Emerging evidence demonstrates that while MBS produces greater and more durable weight loss than GLP-1 RAs alone, these therapies need not be competitive. Rather, GLP-1 RAs may serve as 'neoadjuvant' treatment to optimize surgical candidacy or as adjunctive treatment for inadequate weight loss or postoperative weight regain. This review synthesizes contemporary data on MBS procedures, outcomes, disparities in access, and evolving perceptions of obesity treatment in the GLP-1 RA era. We propose a chronic weight management model that integrates pharmacotherapy, surgery, and multidisciplinary care along a continuous treatment spectrum. Positioning MBS and GLP-1 RAs as complementary modalities within individualized care pathways may improve long-term outcomes, expand access, and better address the complex, chronic nature of obesity.</p>","PeriodicalId":45386,"journal":{"name":"Journal of Obesity & Metabolic Syndrome","volume":" ","pages":""},"PeriodicalIF":12.7,"publicationDate":"2026-10-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149128720","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Alejandro Gómez-Bruton, Helder Fonseca, Susana Ara-Gimeno, Angel Matute-Llorente, Lucas Veras, Gabriel Lozano-Berges, Cláudia Mendes, Jorge Bravo, Manuel Carvalho, Pilar Irún, Ana Moradell, Maria Jose Palacios Fanlo, Marta Sánchez-Luengo, Gonzalo Hijos-Mallada, German Vicente-Rodríguez, Armando Raimundo, Angel Lanas, Jose A Casajus
{"title":"Validation of Predictive Equations for Estimating Lean Soft Tissue and Fat-Free Mass in Class II-V Obesity: A Multicenter Observational Study with Implications for Bariatric Surgery Monitoring.","authors":"Alejandro Gómez-Bruton, Helder Fonseca, Susana Ara-Gimeno, Angel Matute-Llorente, Lucas Veras, Gabriel Lozano-Berges, Cláudia Mendes, Jorge Bravo, Manuel Carvalho, Pilar Irún, Ana Moradell, Maria Jose Palacios Fanlo, Marta Sánchez-Luengo, Gonzalo Hijos-Mallada, German Vicente-Rodríguez, Armando Raimundo, Angel Lanas, Jose A Casajus","doi":"10.7570/jomes25065","DOIUrl":"10.7570/jomes25065","url":null,"abstract":"<p><strong>Background: </strong>Preoperative analysis of body composition is critical for anticipating metabolic changes and optimizing outcomes after bariatric surgery (BS). This study assessed agreement between dual-energy X-ray absorptiometry (DXA)-derived fat-free mass (FFM) and lean soft tissue (LST) and estimates from anthropometric equations in individuals with class-II obesity or greater.</p><p><strong>Methods: </strong>FFM and LST were measured by DXA in 123 participants with class-II obesity or greater before and approximately 1 month after BS. Six equations were used to estimate FFM and five to estimate LST. The estimates were calculated at both time points, and changes from pre- to post-BS were compared with the DXA-derived values. Paired <i>t</i>-tests were used to evaluate differences between the predicted and measured values.</p><p><strong>Results: </strong>At the group level, the Li et al. equation for higher body mass index (BMI) values demonstrated the highest agreement with DXA-FFM before surgery (mean-difference, 0.01 kg; 95% confidence interval [CI], -0.74 to 0.74), whereas the Li et al. equation for normal BMI values showed the greatest agreement at follow-up (mean-difference, 1.71 kg; 95% CI, 1.30 to 2.13). For LST estimation, the Salamat et al. equation provided the greatest accuracy before BS (mean-difference, 0.03 kg; 95% CI, -1.35 to 1.40), and the Kulkarni et al. equation achieved the best performance in capturing group-level changes during follow-up (mean-difference, 0.48 kg; 95% CI, 0.05 to 0.92).</p><p><strong>Conclusion: </strong>Although certain predictive equations yielded acceptable group-level agreement with DXA, their individual-level performance was inconsistent, limiting their clinical utility. Further research is warranted to develop predictive models with enhanced precision and reliability.</p>","PeriodicalId":45386,"journal":{"name":"Journal of Obesity & Metabolic Syndrome","volume":" ","pages":"335-348"},"PeriodicalIF":12.7,"publicationDate":"2026-07-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13429821/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147692724","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Dafne Ferrari, Valerio Bonavolontà, Matteo Campanella, Ludovica Cardinali, Lavinia Falcioni, Gian Pietro Emerenziani, Silvia Migliaccio, Edoardo Mocini, Marco Meucci, Carlo Baldari, Andrea De Giorgio, Laura Guidetti
{"title":"Response: Could a Short Incremental Test Be a Valid Cardiorespiratory Efficiency Assessment Tool in Obese Adults? A Comparison between Two Exercise Testing Protocols (J Obes Metab Syndr 2025;34:282-90).","authors":"Dafne Ferrari, Valerio Bonavolontà, Matteo Campanella, Ludovica Cardinali, Lavinia Falcioni, Gian Pietro Emerenziani, Silvia Migliaccio, Edoardo Mocini, Marco Meucci, Carlo Baldari, Andrea De Giorgio, Laura Guidetti","doi":"10.7570/jomes26004","DOIUrl":"10.7570/jomes26004","url":null,"abstract":"","PeriodicalId":45386,"journal":{"name":"Journal of Obesity & Metabolic Syndrome","volume":" ","pages":"378-380"},"PeriodicalIF":12.7,"publicationDate":"2026-07-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13429813/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148413296","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}